IPOs and Secondaries

Fannie Mae is now faced with a double whammy of rising interest rates and an almost-certain collapse of homebuyers. What are the prospects for a public offering of Fannie Mae stock in 2021?
Paul Ausick
Tilray chose perhaps the worst time that it could to raise capital, as the prior trading day was the worst one that the markets have seen since the 1987 crash.
Jon C. Ogg
Enphase Energy has seen its shares surge over the past year. Now the company is using some of the great stock performance to raise capital.
Jon C. Ogg
The analysts at its underwriting firms are quite positive on Beam Therapeutics, now that its post-IPO quiet period has come to an end.
Jon C. Ogg
Having a base in multiple jurisdictions can be tricky. Just ask Yandex N.V. (NASDAQ: YNDX).  The company is one of the top internet companies in Europe and is the considered to be the leading search...
Jon C. Ogg
When the value of a stock keeps rising over time, it tends to look and feel good for just about everyone involved. That said, sometimes things have become so rewarding that some companies decide to...
Jon C. Ogg
Tesla has been a market darling over the past six months, with the stock more than doubling. CEO Elon Musk is looking to capitalize on this move with a secondary offering, but are shares being...
Chris Lange
The White House has announced a plan to overhaul Fannie Mae that includes a return to private control after recapitalization via an initial public offering.
Paul Ausick
Tesla has filed preliminary documents with the SEC to offer 2.65 million shares of stock in a follow-on offering that would generate around $2 billion in cash at the stock's current share price.
Paul Ausick
Revolution Medicines entered the market with a bang on Thursday. Although the company only priced shares are $17 apiece, the stock actually entered the market closer to $28.
Chris Lange
Moderna Inc. (NASDAQ: MRNA) had been the biggest biotech initial public offering ever. The company was quite unlucky in the timing for its IPO, but it managed to get back into favor with investors....
Jon C. Ogg
PPD made an exciting entrance to the market Thursday, pricing its shares at the high end of the expected price range.
Chris Lange
Casper Sleep entered the market with a bang despite some trepidation going into the IPO.
Chris Lange
Merck finds itself in a position of being an acquirer of sorts at the same time it wants to spin out part of its operations. Executing this effort may create some operational uncertainty inside of...
Jon C. Ogg
Casper Sleep, a maker of sleep-related items, now intends to price more than 8 million shares for an initial public offering valued up to almost $125 million.
Chris Lange